Evidence map›Paper›PMID 36937372›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2023

The impact of COVID-19 and COVID vaccination on cardiovascular outcomes.

Zubair Akhtar, Mallory Trent, Aye Moa, Timothy C Tan, Ole Fröbert, C Raina MacIntyre

Open access · hybridAbstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. [Severe coronavirus-2 infection background for cardiovascular complications].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Zubair AkhtarBiosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Mallory TrentBiosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Aye MoaBiosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.
Timothy C TanDepartment of Cardiology, Blacktown Hospital, University of Western Sydney, 2148, Blacktown, NSW, Australia.
Ole FröbertDepartment of Cardiology, Faculty of Medicine and Health, Örebro University, Örebro 8200, Sweden.
C Raina MacIntyreBiosecurity Program, The Kirby Institute, University of New South Wales (UNSW), 2052, Sydney Australia.ORCID https://orcid.org/0000-0002-3060-0555
UNSW Sydney · AUInternational Centre for Diarrhoeal Disease Research · BDSteno Diabetes Centers · DKThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or pericarditis. Patients with COVID-19 may present with non-specific symptoms that have a cardiac origin. This review examines the cardiovascular complications of COVID-19 infection and the impact of COVID-19 vaccination. COVID-19 cardiovascular complications include myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, arrhythmias, and persistent post-acute risk of adverse cardiovascular outcomes. Diagnostic and referral pathways for non-specific symptoms, such as dyspnoea and fatigue, remain unclear. COVID-19 vaccination is cardioprotective overall but is associated with myopericarditis in young males, though at a lower rate than following SARS-CoV-2 infection. Increased awareness among primary care physicians of potential cardiovascular causes of non-specific post-COVID-19 symptoms, including in younger adults, such as fatigue, dyspnoea, and chest pain, is essential. We recommend full vaccination with scheduled booster doses, optimal management of cardiovascular risk factors, rapid treatment of COVID-19, and clear diagnostic, referral, and management pathways for patients presenting with non-specific symptoms to rule out cardiac complications.

Indexed as

CardiovascularCOVID-19HeartSARS-CoV-2Vaccines

Identifiers

PMID36937372
PMCPMC10021497
OpenAlexW4320712090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.